UCLA researchers found that two proteins doctors use to check for heart damage can also predict cancer years before symptoms ...

This tumor glycoepitope is expressed by 65% of high-grade serous ovarian carcinoma (HGSOC ... a single intensity threshold was determined to classify tumor cells (pan-CK+) as positive or negative for ...

Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

According to a recent study published in JACC: Advances, researchers have discovered that certain blood markers typically ...

Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

Discover the innovation behind the cancer test that identifies tumor markers in blood samples long before symptoms emerge.

A new kind of cancer test could soon change how doctors detect deadly diseases—quickly, cheaply, and almost anywhere. A team ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Department of Radiation Oncology and Molecular Radiation Sciences ...

The global Fiducial Markers Market is estimated to be valued at USD 186.8 million in 2025 and is projected to reach USD 430.2 million by 2035, registering a compound annual growth rate (CAGR) of 8.7% ...

Proliferating cells, in particular tumor cells, are characterized by a high amount of the dimeric ... In combination with established tumor markers, EDTA-plasma Tumor M2-PK is a useful tool ...

The global Fiducial Markers Market is estimated to be valued at USD 186.8 million in 2025 and is projected to reach USD 430.2 ...

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...